Imago Biosciences Sees $26.5M
San Francisco-based biotechnology developer Imago BioSciences said last week that it has raised $26.5M in a Series A funding. The funding came from Clarus Ventures, along with Frazier Healthcare, Amgen Ventures, and Merck Research Labs Venture Fund. Imago Biosciences is working on therapeutics that alter gene expression patterns. The company said that Clarus Ventures and Frazier Healthcare both gain a seat on the company's board. Imago BioSciences is led by Hugh Young Rienhoff.
posted on Monday, November 3, 2014 (Link to more information)
Related companies:
Imago Biosciences
Related stories:
> 3-V Biosciences Finds $20M In Funding
> Pacific Biosciences Raises $50M
> Annexon Biosciences Gets $44M
> Flexus Biosciences Acquired For $1.25 Billion
> Pacific Biosciences Gains $109M
silicontap.com Home